Literature DB >> 15883314

Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.

O L Lopez1, L H Kuller, J T Becker, W J Jagust, S T DeKosky, A Fitzpatrick, J Breitner, C Lyketsos, C Kawas, M Carlson.   

Abstract

OBJECTIVE: To describe the diagnostic classification of subjects with incident vascular dementia (VaD) participating in the Cardiovascular Health Study (CHS) Cognition Study.
METHODS: The CHS classified 480 incident cases between 1994 and 1999 among 3,608 CHS participants who had brain MRI in 1992 through 1994 and in 1997 through 1998. The patients were diagnosed before and after reviewing the brain MRI.
RESULTS: The pre-MRI classification showed that 52 participants had VaD and 76 had both Alzheimer disease (AD) and VaD. The post-MRI classification showed that the Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV) criteria classified 61 subjects as having VaD, the National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINDS-AIREN) criteria classified 43 subjects as having probable VaD and 10 as possible VaD, and the State of California Alzheimer's Disease Diagnostic and Treatment Center (ADDTC) criteria classified 117 as having probable VaD and 96 as possible. The combination of the ADDTC and National Institute of Neurological and Communication Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria was used to examine the spectrum of vascular disease in dementia. The dementia was attributable to only vascular factors in 56 cases (probable VaD); VaD coexisted with AD in 61 cases, although the VaD component was the leading cause of dementia (probable VaD with AD); AD was the leading cause of dementia in 61 cases (possible VaD and probable AD); and in 29 cases, it was not clear that either AD or VaD was the primary diagnosis (possible AD and possible VaD).
CONCLUSIONS: None of the clinical criteria for VaD identified the same group of subjects. The diagnosis of vascular dementia is difficult in epidemiologic studies because poststroke dementia can be due to Alzheimer disease (AD) and evidence of vascular disease can be found in the MRI of dementia cases without clinical strokes. Whether the clinical progression is related to AD pathology or vascular disease is difficult to establish.

Entities:  

Mesh:

Year:  2005        PMID: 15883314     DOI: 10.1212/01.WNL.0000159860.19413.C4

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

1.  Large Perivascular Spaces Visible on Magnetic Resonance Imaging, Cerebral Small Vessel Disease Progression, and Risk of Dementia: The Age, Gene/Environment Susceptibility-Reykjavik Study.

Authors:  Jie Ding; Sigurður Sigurðsson; Pálmi V Jónsson; Gudny Eiriksdottir; Andreas Charidimou; Oscar L Lopez; Mark A van Buchem; Vilmundur Guðnason; Lenore J Launer
Journal:  JAMA Neurol       Date:  2017-09-01       Impact factor: 18.302

Review 2.  Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder.

Authors:  Robert W Van Boven; Greg S Harrington; David B Hackney; Andreas Ebel; Grant Gauger; J Douglas Bremner; Mark D'Esposito; John A Detre; E Mark Haacke; Clifford R Jack; William J Jagust; Denis Le Bihan; Chester A Mathis; Susanne Mueller; Pratik Mukherjee; Norbert Schuff; Anthony Chen; Michael W Weiner
Journal:  J Rehabil Res Dev       Date:  2009

3.  Social engagement and physical and cognitive health among American Indian participants in the health and retirement study.

Authors:  Lonnie A Nelson; Carolyn J Noonan; Jack Goldberg; Dedra S Buchwald
Journal:  J Cross Cult Gerontol       Date:  2013-12

4.  Vascular dementia.

Authors:  Ae Young Lee
Journal:  Chonnam Med J       Date:  2011-08-31

5.  PET in Cerebrovascular Disease.

Authors:  William J Powers; Allyson R Zazulia
Journal:  PET Clin       Date:  2010-01-01

6.  Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study.

Authors:  C Qiu; M F Cotch; S Sigurdsson; P V Jonsson; M K Jonsdottir; S Sveinbjrnsdottir; G Eiriksdottir; R Klein; T B Harris; M A van Buchem; V Gudnason; L J Launer
Journal:  Neurology       Date:  2010-12-14       Impact factor: 9.910

Review 7.  Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms.

Authors:  Laure Rouch; Philippe Cestac; Olivier Hanon; Charlène Cool; Catherine Helmer; Béatrice Bouhanick; Bernard Chamontin; Jean-Franҫois Dartigues; Bruno Vellas; Sandrine Andrieu
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

Review 8.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

9.  Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study.

Authors:  W L Xu; E von Strauss; C X Qiu; B Winblad; L Fratiglioni
Journal:  Diabetologia       Date:  2009-03-12       Impact factor: 10.122

10.  Albuminuria and dementia in the elderly: a community study.

Authors:  Joshua I Barzilay; Annette L Fitzpatrick; Jose Luchsinger; Sevil Yasar; Charles Bernick; Nancy S Jenny; Lewis H Kuller
Journal:  Am J Kidney Dis       Date:  2008-05-12       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.